Guardant Health Overview
Guardant Health Target Price
Analysts' 12-month price predictions for GH.
Share Price
$60.13
Average Target Price
$70.00
16.4% upside
16.4% upside1 analysts in the last 4 months
High: $70 | Low: $70
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-25 | China Renaissance Securities (US) Inc.Tempus AI | $70 | 16.4% upside |  |
| 2025-03-05 | Morgan Stanley | $52 |  13.5% downside | |
| 2024-08-21 | UBSDan Leonard | $40 | 33.5% downside | |
| 2024-08-08 | Craig-HallumBill Bonello | $37 | 38.5% downside | |
| 2024-08-08 | JefferiesTycho Peterson | $40 | 33.5% downside | |
| 2024-07-29 | BTIGMark Massaro | $50 | 16.8% downside | |
| 2024-06-28 | GuggenheimSubbu Nambi | $36 | 40.1% downside | |
| 2024-06-04 | Canaccord GenuityKyle Mikson | $38 | 36.8% downside | |
| 2024-06-03 | JefferiesTycho Peterson | $32 | 46.8% downside | |
| 2024-05-23 | BTIGMark Massaro | $45 | 25.2% downside | |
| 2024-05-22 | Canaccord GenuityKyle Mikson | $30 | 50.1% downside | |
| 2024-04-24 | Craig-HallumChase Knickerbocker | $28 | 53.4% downside | |
| 2023-09-27 | Piper SandlerDavid Westenberg | $40 | 33.5% downside | |
| 2023-02-06 | Goldman Sachs | $45 | 25.2% downside | |
| 2022-12-16 | Morgan StanleyTejas Savant | $80 | 33% upside | |
| 2022-12-16 | Canaccord GenuityKyle Mikson | $65 | 8.1% upside | |
| 2022-10-05 | StephensMason Carrico | $99 | 64.6% upside | |
| 2022-08-08 | Goldman Sachs | $80 | 33% upside | |
| 2022-05-09 | J.P. MorganJulia Qin | $125 | 107.9% upside | |
| 2021-06-03 | Goldman SachsMatthew Sykes | $160 | 166.1% upside | |